With our long history as a pharmaceutical manufacturer, every project at UPM receives the highest quality with the greatest efficiency and speed possible. We proudly provide uncompromising performance backed by intellectual distinction, top of the line equipment and state of the art processing.
UPM provides cGMP manufacturing for clinical Phase I, II, and III products, including tablets, capsules and semi-solids. We are capable of producing batch sizes ranging from a few thousand units to over a million units per batch.
Every aspect of work at UMP is informed by our extensive experience and handled with the utmost skill. We devote our attention to scientific detailand overall quality. We believe that intellectual distinction and superior performance are the legacies we share with all our clients.
Look to UPM for the highest quality specialty applications. Our capabilities include variable capacity high speed coating equipment, precision processing of fine powders, pellets, granules and crystals, production of high-density, low-excipient granules, and uniform, durable compaction.We provide our clients with versatile applications for every purpose and every step in the clinical manufacturing process. Among the many applications we feature are:
UPM Pharmaceuticals offers encapsulation services using this state-of-the-art, highly precise system for clinical trial supply manufacturing. We use this technology’s CFR 21 Part 11-compliant software to accurately record factors such as the weight of each capsule for the monitoring of batches and individual capsules.
The Xcelodose system is a precision powder micro-dose system and automated encapsulator with a fill range of 100 micrograms to greater than 100 milligrams. UPM leverages its advanced Xcelodose suite establishing a unique ability to provide manufacturing services for early stage clinical trials.
UPM creates manufacturing batches for clinical trials a service that has never been easier or more precise with the Xcelodose 600S automatic precision powder micro-dosing system.
UPM’s Xcelodose suite uses the pepper-pot principle to dispense dose weights as low as 100 micrograms, which allows you to precisely, accurately and repeatedly fill capsules and other small dose containers with active substances alone, without excipients or bulking agents (for the majority of API’s). Most blends, or formulated products, can also be filled without segregation.
This technology enables you to directly fill active pharmaceutical ingredients into capsules at a rate of several hundred capsules per hour. By eliminating the need for excipient compatibility and pre-formulationactivities, first-in-human and first-to-market times can be dramatically shortened.
Implementing the Xcelodose system, UPM can shorten drug development time and speed up time to first-in-human clinical trials.
Precision dosing and optimized filling are just two of the robust features that make the Xcelodose 600S System the choice for pharmaceutical research and development concerns all over the globe. Other innovative features of the Xcelodose system include:
UPM’s Xcelodose suite delivers precision accuracy at high speed with unprecedented ease of control. Let UPM Pharmaceuticals accelerate your company’s drug development cycles and increase profitability with the Xcelodose 600S.